With so many scientific breakthroughs in regenerative medicine, commercial challenges have never been so urgent. Consequences have been suffered by both
pharma and patients when we fail to overcome the barriers from lab to sites of care.
To continuedly create impact from trial to post-launch, we must proactively work with patients, HCPs, regulators, payors and partners to amplify the values of innovation for all stakeholders, and eventually will be able to expand our footprint and pave the road to the next generation medicine.
Rome wasn’t built in a day, but at Pharma USA 2024 (March 26-27, Philadelphia) we’re laying the foundations for your frontline therapy by gathering the industry’s best minds and generating solutions to the space’s biggest commercial challenges.